What an AI benchmark can tell a hospital

Imagine a presentation with two bars. The new AI system is ahead, with the results of human participants beside it. This can represent an impressive technical achievement. Important questions still remain for a hospital's leadership: what exactly was tested, and which part of our own work is comparable?

This gap particularly interests me because I bring together medicine, company building and the perspective of investors. Each asks a different question. Is the claim clinically defensible? Can it become a reliable working process? Does it solve a problem that someone takes responsibility for addressing?

A good benchmark helps answer these questions. Its meaning must remain tied to the conditions in which the result was produced. The essential task is to make the path from measured performance to intended use clear enough to assess.

Three different questions

The first question concerns the model: can it solve a particular task under specified conditions? Cases, answers and a scoring method can be defined for this purpose. That makes performance comparable. The approach is especially useful when the task has clear boundaries and the test material is appropriate.

The second question concerns collaboration: what happens when doctors use the system? The presentation of results, available time, prior knowledge and integration into work all matter. A capable model can be used in several ways. Those applications may produce very different effects.

A randomized study published in 2024 provides an illustration. Fifty doctors worked through clinical case descriptions with or without additional access to a language model. The group with AI did not achieve a statistically significant improvement in diagnostic reasoning scores. The model alone performed better in a supplementary analysis. The study examined case-based tasks using a model available at the time; its findings cannot be directly applied to current models or patient outcomes. [1]

A later Pakistani trial found improved vignette reasoning with GPT-4o after all participants received AI training. Because both groups were trained, it cannot isolate the training effect. Different settings and systems limit comparison with Goh. Neither study measured routine patient outcomes. [5]

The third question concerns care: what consequences does the application have in its intended setting? Better scores for individual answers, faster processing and improved outcomes for patients sit at different levels. The connection between them needs to be examined in each case.

What counts as correct in this test?

Before looking at the score, I would read the assessment criteria. Does the test accept only one correct answer? Does it allow defensible alternatives? How does it handle missing information? Which errors carry the most weight? These are clinical judgments that need to fit the eventual application.

A hypothetical example makes the issue clearer. Two systems summarize the same records. The first retains almost all the information but adds some unsupported claims. The second omits information more often but invents less. Which output is more useful depends on what is missing, how consequential the additions would be and how review is organized.

An aggregate score can conceal these differences. When choosing a system, I would therefore examine specific types of error as well. An omitted minor detail, a number assigned to the wrong item and an unsupported recommendation might receive the same formal penalty while having very different consequences in practice.

The reference standard deserves attention too. A historical entry records what was documented at the time. Whether it provides a suitable reference for the current task requires clinical judgment. Clear errors, legitimate differences of opinion and incomplete information can occur alongside one another.

This care should make evaluation more precise. It would be premature to conclude from difficult borderline cases that medical AI is inherently hard to assess in any useful way. Many tasks permit well-founded criteria. The important step is to disclose those criteria and explain the limits of their application.

The distance from your own setting

Next, I would examine the distance between the studied situation and the planned use. Do the data come from a similar care setting? Were difficult or incomplete cases included? What language were the records in? What information was actually available at the time of the decision?

These are practical questions for a German hospital. Terminology, documentation formats and handovers may differ from those in the institution studied. That does not automatically determine whether a system is suitable. It identifies what needs to be examined when transferring it to a new setting.

The STARD-AI reporting guideline was developed to make studies of AI diagnostic accuracy more transparent. [3] For early clinical evaluations, DECIDE-AI also focuses attention on use in real conditions and the people involved. [2] Such guidelines make the research easier to assess; they do not replace the decision about a specific product.

A defensible transfer also requires knowing which version of the system was tested. A result refers to a particular combination of model, instructions, data processing and presentation. When important components change, the supplier should explain which earlier findings still hold and which have been tested again.

Eight questions that make procurement more concrete

The different evaluation levels can be turned into a short request to a supplier. The following questions are my adaptation for procurement. STARD-AI and DECIDE-AI indicate the information that makes a study assessable; they are reporting guidelines. These questions constitute neither product certification nor a complete assessment of every requirement for a particular use. [2] [3]

• What exact use was evaluated? Please identify the task, intended users, system version and position in the workflow. The answer should match the offered application, including material differences from the version studied.
• Which cases reached the analysis? Please show data origin, language, selection and exclusions, and handling of missing inputs. Cases where the system produced no usable result also matter.
• How was a correct answer established? Please explain the reference standard, scoring and handling of disagreement. A recorded historical decision does not become a suitable reference answer merely because it exists.
• What was actually compared? Please describe the information, tools and time conditions available to both groups. Comparing isolated answer tasks addresses a different question from comparing complete workflows.
• Which errors does the overall score conceal? Please show specific error types, their frequency and uncertainty in the estimate. For important subgroups, the number of observations should be visible; a small denominator may mean substantial uncertainty.
• What changed when people used the system? Please describe preparation, actual use, rejected suggestions and remaining rework. The answer should distinguish the model's capability from the effect of its use.
• Which problems were recorded during evaluation? Please describe outages, unusable outputs and workflow changes. The hospital can then determine what a safe interruption and return to the previous procedure might require.
• What remains valid after a change? Please identify relevant changes to the model, data processing or presentation and the evaluation available for them. Our trial should specify responsibility, observation and the trigger for a new decision.

Imagine a fictional response: a supplier reports 90% correct results on 200 carefully selected English-language exercise cases. The hospital plans to use German-language documents with frequently missing information. The offered evidence is therefore narrower than the intended use. The next step might examine precisely that transfer question. Until then, the 90% should not enter a decision brief as the performance expected in the hospital.

A missing answer is also a result of the request. It may justify narrowing the intended use, asking for further documentation or deferring a decision. The task is to connect the unanswered question visibly to the decision that depends on it. A longer reference list does not supply that connection.

What decision should the trial enable?

For an adoption project, I would first describe the intended use in a short statement. Who will use the system for which task? Which decision remains with whom? What would count as an improvement over current practice? Making that explicit brings much greater clarity to the choice of measures.

For a documentation application, for example, the aim might concern total effort until a checked version is ready. Errors, rework and the burden on users would also matter. Diagnostic support would require different outcomes and a different evaluation approach. The demands placed on the assessment should follow from the task and its possible consequences.

For ongoing observation, it is useful to distinguish outcome, process and balancing measures. The Institute for Healthcare Improvement uses these to make intended gains and possible disadvantages elsewhere visible together. Shorter processing time would then be examined alongside quality and any additional steps created. [4]

A time-limited trial can answer important questions about usability or integration. Depending on the intended use, other evidence may be required as well. A supplier and a hospital should therefore state explicitly which decision a particular study is meant to support and which questions will remain open afterwards.

Before selecting a system, I would put three things side by side: the technical evaluation results, a description of the intended working process and the plan for assessing actual effects. If all three concern the same task, the discussion becomes much more concrete. It becomes possible to decide, with reasons, which next step the available evidence supports.